General Information
Drug ID
DR00895
Drug Name
Chlorambucil
Synonyms
Ambochlorin; Amboclorin; C0253; CB 1348; CB-1348; CB1348; Cb l348; Chlocambucil; Chloorambucol; Chlorambucil (USP/INN); Chlorambucil [INN:BAN]; Chlorambucilum; Chlorambucilum [INN-Latin]; Chloraminophen; Chloraminophene; Chlorbutin; Chlorbutine; Chlorbutinum; Chloroambucil; Chlorobutin; Chlorobutine; Clorambucile; Clorambucile [DCIT]; Clorambucilo; Clorambucilo [INN-Spanish]; Ecloril; Elcoril; Elcorin; Glaxo Wellcome Brand of Chlorambucil; GlaxoSmithKline Brand of Chlorambucil; LEUKERAN (TN); Leuk ersan; Leukeran; Leukeran (TN); Leukeran tablets; Leukersan; Leukoran; Linfolizin; Linfolysin; Lympholysin; Phenylbuttersaeure-lost; Phenylbuttersaeure-lost[German]; Phenylbutyric acid nitrogen mustard; Wellcome Brand of Chlorambucil
Drug Type
Small molecular drug
Indication Chronic lymphocytic leukemia [ICD11: 2A82.0] Approved [1]
Therapeutic Class
Anticancer Agents
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=2708"></iframe>
3D MOL 2D MOL
Formula
C14H19Cl2NO2
Canonical SMILES
C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl
InChI
InChI=1S/C14H19Cl2NO2/c15-8-10-17(11-9-16)13-6-4-12(5-7-13)2-1-3-14(18)19/h4-7H,1-3,8-11H2,(H,18,19)
InChIKey
JCKYGMPEJWAADB-UHFFFAOYSA-N
CAS Number
CAS 305-03-3
Pharmaceutical Properties Molecular Weight 304.211 Topological Polar Surface Area 40.5
Heavy Atom Count 19 Rotatable Bond Count 9
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 3
XLogP
1.7
PubChem CID
2708
ChEBI ID
ChEBI:28830
TTD Drug ID
D0V8QT
DT(s) Transporting This Drug OATP1A2 Transporter Info Organic anion transporting polypeptide 1A2 Substrate [2]
P-GP Transporter Info P-glycoprotein 1 Substrate [3]
References
1 Chlorambucil was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Transporters and renal drug elimination. Annu Rev Pharmacol Toxicol. 2004;44:137-66.
3 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.